University Of Michigan Comprehensive Cancer Center is a clinical research site located in Ann Arbor, Michigan, United States 48109-5946.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
University Of Michigan Comprehensive Cancer Center has participated in 7 clinical trials with 3 currently active.
Therapeutic areas: Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse.
Sponsors: Bristol-Myers Squibb, Celgene, Juno Therapeutics, a Subsidiary of Celgene.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University Of Michigan Comprehensive Cancer Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University Of Michigan Comprehensive Cancer Center has 7 clinical trials on record, with 3 currently active. Their work covers Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse.
Yes — University Of Michigan Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.